Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LYEL

Lyell Immunopharma, Inc.

CIK 0001806952 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$15.53
↑ 0.18 (1.17%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$380.56M
P/E Ratio
-1.53
EPS
-16.06
Dividend Yield
Not covered
52W Position
15%
Beta
1.70

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.63
P/S
Not covered
EV/Revenue
Not covered
ROE
-106.3%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 15%
$10.49$45.00

Latest Financials

2025-12-31 FY
Revenue
$36.00K
Net Income
-$274.45M
Total Assets
$340.05M
Free Cash Flow
-$150.80M

Recent news